![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Thursday, June 24, 2021 7:44:42 PM
Drug containing the active ingredient Aviptadil for inhalation/topical therapy.
Aviptadil (Vasoactive intestinal peptide (VIP)) is a peptide in the body that is already approved for another indication (ectile dysfunction) with an excellent safety profile.
The preclinic for inhalation therapy is available. Studies and casuistics show excellent efficacy and compatibility of the drug
Patients with sarcoidosis and related diseases (e.g. Berylliosis), have already benefited significantly from off-label treatment, so that many health insurance companies bear the treatment costs.
The simple application is done with a nebulizer of the latest generation.
In addition to product development for human medicine, products for veterinary medicine (especially for horses) are also to be developed.
https://advita-lifescience.com/wirkstoffe/
~ Money Making Money ~
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM